Figure 4.
Kaplan-Meier survival curves comparing patients with SMZL with mutated and nonmutated IgVH genes. Patients with nonmutated IgVH genes had significantly shorter related-disease overall survival (DOS) (A) and progression-free interval (PFI) (B).